Literature DB >> 1863696

Sedative-hypnotic drug use in Canada.

N S Rawson1, C D'Arcy.   

Abstract

Although many studies of sedative-hypnotic drug use have been performed in Canada, there has been no national study of the use of these drugs. We have attempted to correct this deficit in our knowledge by using data from an international survey of health care utilization performed in 1968-9 and from the Canada Health Survey (1978-9), the Health Promotion Survey (1985) and the National Alcohol and Other Drugs Survey (1989) to examine sedative-hypnotic use among individuals aged 15 or more. The results suggest that the use of these drugs in Canada is about average for an industrialized society. Several socioeconomic and health care correlates of sedative-hypnotic use were found. The rate of use of these drugs was higher among women, the elderly, separated, divorced or widowed individuals, those who had a secondary school education or less, individuals with a low family income, the retired, and the unemployed. Among women, higher rates of use were reported by those whose main activity was keeping house (as compared with those who were employed outside the home) and by those who lived alone. Higher rates of use were also found for individuals who had consulted a physician or been hospitalized recently, individuals taking multiple drugs, those who scored highly on an anxiety scale, persons in whom negative feelings predominated, and those who had experienced a high frequency of psycho-physiological symptoms of anxiety and depression. From a regional point of view, the highest rates of use for women were consistently reported from Quebec, while the lowest were consistently found in the Prairie provinces. No consistent pattern was found for men.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863696

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  5 in total

Review 1.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Questionable prescribing for elderly patients in Quebec.

Authors:  R M Tamblyn; P J McLeod; M Abrahamowicz; J Monette; D C Gayton; L Berkson; W D Dauphinee; R M Grad; A R Huang; L M Isaac
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

3.  A population-wide profile of prescription drug use in Saskatchewan, 1989.

Authors:  K Quinn; M J Baker; B Evans
Journal:  CMAJ       Date:  1992-06-15       Impact factor: 8.262

Review 4.  Pharmacotherapy of insomnia: practice and prospects.

Authors:  J Dingemanse
Journal:  Pharm World Sci       Date:  1995-05-26

5.  Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians.

Authors:  Aliya Kassam; Scott B Patten
Journal:  Popul Health Metr       Date:  2006-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.